Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine

Awarded Award Notice Posted

Solicitation number
PHS2021-1
Agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Awarded
to Zymeron Corporation
Set-aside
Total Small Business

Opportunity facts

Contract number
75N93021C00025 Federal contract award
NAICS code
54171 Research and Development in the Physical, Engineering, and Life Sciences
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Place of performance
Durham, North Carolina 27709, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Zymeron Corporation was awarded a contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to develop an Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine. Under the $300,000 contract, Zymeron will utilize virus-mimicking nanoparticles combined with an adjuvant to enhance the immune response in their work developing an HIV vaccine for the agency over the coming year, as specified in the award notice published on September 23, 2021 under a total small business set aside.

Notice text

Awarded contract 75N93021C00025 to Zymeron Corporation for 300000.00 on 2021-07-01.

Notice history

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity